Showing results (901-910 of 989) with videos related to

Sort By:
Pageof 99
Bioorganic & Medicinal Chemistry Letters|January 28, 2017
Synthesis, characterization, in vitro SAR and in vivo evaluation of N,N'bisnaphthylmethyl 2-alkyl substituted imidazolium salts against NSCLCMichael A DeBord, Marie R Southerland, Patrick O Wagers, et al.
ACS Pharmacology & Translational Science|April 17, 2020
The European Research Network on Signal Transduction (ERNEST): Toward a Multidimensional Holistic Understanding of G Protein-Coupled Receptor SignalingMartha E Sommer, Jana Selent, Jens Carlsson, et al.
Journal of Cellular and Molecular Medicine|January 10, 2023
Fluorescence in situ hybridization test for detection of endometrial carcinoma cells by non-invasive vaginal swabJörg Weimer, Martje Hüttmann, Asiyan Nusilati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study GroupW Hiddemann, M Unterhalt, R Herrmann, et al.
Pathology, Research and Practice|November 8, 2017
EGFR immunohistochemistry as biomarker for antibody-based therapy of squamous NSCLC - Experience from the first ring trial of the German Quality Assurance Initiative for Pathology (QuIP®)Iver Petersen, Manfred Dietel, Wolf J Geilenkeuser, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 28, 2022
Processes and perceptions of chemotherapy supply chain in Ethiopia: A mixed-method studyKurtis J Stocker, Andrew Tiemann, Kelly M Brunk, et al.
BJU International|January 14, 2010
Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trialChristian Bolenz, Edwin Herrmann, Patrick J Bastian, et al.
Pediatric Research|December 14, 1999
Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Société d'Hématologie et d'Immunologie Pédiatrique (SHIP), Gesellshaft für Pädiatrische Onkologie und Hämatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI)T N Willig, C M Niemeyer, T Leblanc, et al.
Leukemia|May 1, 1996
Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study GroupM Unterhalt, R Herrmann, M Tiemann, et al.
Pathologie (Heidelberg, Germany)|October 24, 2023
Testing for deficient mismatch repair and microsatellite instability : A focused updateJosef Rüschoff, Hans-Ulrich Schildhaus, Jan Hendrik Rüschoff, et al.
Pageof 99